All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Use of biologics for psoriasis in Central and Eastern European countries

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11120%2F15%3A43910448" target="_blank" >RIV/00216208:11120/15:43910448 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064173:_____/15:#0000501

  • Result on the web

    <a href="http://dx.doi.org/10.1111/jdv.13222" target="_blank" >http://dx.doi.org/10.1111/jdv.13222</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/jdv.13222" target="_blank" >10.1111/jdv.13222</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Use of biologics for psoriasis in Central and Eastern European countries

  • Original language description

    ObjectivesTo evaluate the use of biological agents for the treatment of psoriasis and to explore country-specific differences within six Central and Eastern European (CEE) countries, namely Bulgaria, Croatia, the Czech Republic, Hungary, Poland and Romania. MethodsA literature overview on the epidemiology and disease burden of psoriasis in CEE was conducted. The number of patients treated with biologics was obtained from patient registries, ministries of health, national professional societies and health insurance funds. Biological treatment rates were estimated by two different methods: (i) as a proportion of all psoriasis patients of a country (assuming a common prevalence of psoriasis 2%) and (ii) per 100000 population. Moreover, we provide a detailed comparison of drug coverage policies and guidelines regulating the treatment with biologics in psoriasis. ResultsOn average 0.25% of all psoriasis patients, or five psoriasis patients out of 100000 inhabitants are treated with biologic

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FO - Dermatology and venereology

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    N - Vyzkumna aktivita podporovana z neverejnych zdroju

Others

  • Publication year

    2015

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of the European Academy of Dermatology and Venereology

  • ISSN

    0926-9959

  • e-ISSN

  • Volume of the periodical

    29

  • Issue of the periodical within the volume

    11

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

    2222-2230

  • UT code for WoS article

    000363983000021

  • EID of the result in the Scopus database